The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study (Q85115903)

From Wikidata

Jump to navigation Jump to search

scientific article published on 02 October 2010

Language	Label	Description	Also known as
English	The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study	scientific article published on 02 October 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study (English)

1 reference

10.1016/J.UROLONC.2010.07.015

https://api.crossref.org/works/10.1016/J.UROLONC.2010.07.015

23 July 2024

author name string

Valentina Baldazzi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Renato Tassi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Alberto Lapini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Carmine Santomaggio

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Marco Carini

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Roberto Mazzanti

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20884255

23 July 2024

publication date

2 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S1078143910001894?httpAccept=text/xml

1 reference

10.1016/J.UROLONC.2010.07.015

https://api.crossref.org/works/10.1016/J.UROLONC.2010.07.015

23 July 2024

https://api.elsevier.com/content/article/PII:S1078143910001894?httpAccept=text/plain

1 reference

10.1016/J.UROLONC.2010.07.015

https://api.crossref.org/works/10.1016/J.UROLONC.2010.07.015

23 July 2024

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

704-710

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Sunitinib and Hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

A Novel Tyrosine-Kinase Selective Inhibitor, Sunitinib, Induces Transient Hypothyroidism by Blocking Iodine Uptake

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Association between development of hypothyroidism and improved survival in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Cell-surface receptor for thyroid hormone and tumor cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Interferon-alpha and autoimmune thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Imatinib induces hypothyroidism in patients receiving levothyroxine

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Documentation of thyroid function in clinical studies with sunitinib: why does it matter?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.015

7 January 2021

Identifiers

10.1016/J.UROLONC.2010.07.015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884255%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85115903&oldid=2211406151"